NewsBenzingaClover Health Investments aumenta la guidance sulle vendite per l’esercizio 2026 da 2,920 miliardi di dollari–3,000 miliardi di dollari a 2,970 miliardi di dollari–3,000 miliardi di dollari, rispetto ai 2,954 miliardi di dollari stimati Clover Health Investments aumenta la guidance sulle vendite per l’esercizio 2026 da 2,920 miliardi di dollari–3,000 miliardi di dollari a 2,970 miliardi di dollari–3,000 miliardi di dollari, rispetto ai 2,954 miliardi di dollari stimati Benzinga 2026.11.04 21:17 (GMT+0) Open on Benzinga Other news Rep. Byron Donalds Sells Netflix Stock for Loss: Here’s What He’s Buying Instead StoneX Group Q4 EPS $0.66 Down From $0.70 YoY, Sales $1.461B Up From $1.202B YoY QUICK SPARK: Intel Stock Eyes Worst Two-Month Drop on Record After Triple-Digit Rally Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate WesBanco Raises Quarterly Cash Dividend From $0.38 To $0.39 Per Share Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029
Red Robin Gourmet Burgers Q3 Adj. EPS $(0.54) Misses $(0.40) Estimate, Sales $232.098M Miss $252.090M Estimate
Universal Technical Expects More Than $1B Revenue And Nearly $150M Adjusted EBITDA In FY28; Sees Revenue Exceeding $1.2B And EBITDA Approaching $220M By Fiscal 2029